article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

The company, a spin-out from the UW’s Institute for Protein Design , is developing vaccines to resemble naturally occurring viruses. Icosavax is also developing shots, geared for older adults, against two viruses that cause pneumonia, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Net losses were $5.3

article thumbnail

Tech Moves: Top Blue Origin engineer joins SpaceX; Axon hires HTC Vive exec; Porch adds to board

GeekWire

Prior to joining Convoy in 2018, Kreiner was CEO of Cal Net Technology Group and a managing partner at Olympic Valley Capital. New Athira execs Mark Worthington, general counsel, and Rachel Lenington, chief technology officer and head of product development strategy. Athira Photos). Read the story. Lessen Photo). Scottsdale, Ariz.-based

CTO Hire 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NLP helps Eli Lilly work at a global scale

CIO Business Intelligence

With more than 30,000 employees spread across more than 60 affiliate locations and 14 manufacturing sites around the world, pharmaceutical company Eli Lilly operates at a truly global scale. The Lilly Translate API and UI are delivered via a serverless tech stack built on Node.js, Python,NET, and Docker.

article thumbnail

Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships

GeekWire

The Seattle-based company posted a net loss of $31.4 million a year ago, as it almost doubled its research and development spending. The goal is to develop therapies to treat the virus. million, or 25 cents a share, vs. a loss of $18.4 Wall Street analysts expected Adaptive to post revenue of $22.7

article thumbnail

The major blind spot in Bill Gates’s pandemic prevention plan

Vox

But for Gates, philanthropy is the cure for inequality, and business-driven tech and science development will save us from another Covid-19. “I Pharmaceutical companies raked in record profits from Covid-19 drugs and vaccines; tech stocks boomed , and the number of billionaires around the world shot up by 30 percent.

article thumbnail

Our favorite startup pitches from Techstars Seattle Demo Day

GeekWire

Techstars Photo) Founders : Hiep Luong , Jason Cheong , Rohit Kuma Silico Data Services CEO Hiep Luong , who spent more than a decade at pharmaceutical giant Gilead Sciences, said he was “shocked” when the FDA put a hold on the Johnson & Johnson vaccine because of quality issues. The average tow company pays us $400 a month.”

article thumbnail

Pfizer will acquire Seattle-area biotech giant Seagen for $43 billion

GeekWire

The company pulled in $2 billion in revenue in 2022, and net product sales increased 23% to $1.7 Last year Pfizer acquired sickle-cell drug company Global Blood Therapeutics for more than $5 billion and completed a deal to acquire migraine drug maker Biohaven Pharmaceuticals. The deal is expected to close in late 2023 or early 2024.